Conference Coverage
Conference Coverage
Reports from the annual meeting of The Connective Tissue Oncology Society held in Rome, November 14-17, 2018 Sarcoma of the Year: Intimal Sarcoma
Sarcoma of the Year: Intimal Sarcoma
Conference Coverage
Extended AI therapy reduces breast cancer recurrence risk, ups fracture risk
SAN ANTONIO – A meta-analysis shows reduced breast cancer recurrence with extended AI therapy, but underscores need...
Conference Coverage
Oxybutynin rapidly quells hot flashes
SAN ANTONIO - Oxybutynin reduced hot flash scores by at least two-thirds, improved measures of quality of life, and was safe and well tolerated in...
Conference Coverage
Phase 3 data support apixaban for cancer-associated VTE
The rate of major bleeding was similar with apixaban and dalteparin.
Conference Coverage
Be judicious with empiric antibiotics for febrile neutropenia
Conference Coverage
Partial- and whole-breast irradiation very close in efficacy
SAN ANTONIO – A phase 3 trial among women who had undergone lumpectomy could not refute the hypothesis that PBI was inferior to WBI, but the...
Conference Coverage
Brain injury in sickle cell merits more attention
BETHESDA, MD – It’s time to consider the silent infarcts of sickle cell patients.
Conference Coverage
MAIA: Daratumumab plus len-dex improves myeloma PFS
SAN DIEGO – Adding the anti-CD38 monoclonal antibody to lenalidomide and dexamethasone significantly decreased 30-month risk of progression.
Conference Coverage
CTC counts signal treatment choice in ER-positive/HER2-negative metastatic breast cancer
SAN ANTONIO – Circulating tumor cell counts rival clinician choice for determining whether to prescribe hormonal therapy or chemotherapy,...
Conference Coverage
NCI director: Data failures cost lives
SAN DIEGO – Too many patients die because numbers aren’t aggregated or shared, Dr. Ned Sharpless said at the ASH meeting.
Conference Coverage
AMAROS: Radiation has edge for axillary treatment
SAN ANTONIO – In patients with a positive sentinel node, axillary radiation has similar efficacy to axillary lymph node dissection and less...